David A Luckenbaugh Selected Research

David A Luckenbaugh Research Topics

Disease

34	Major Depressive Disorder (Major Depressive Disorders) 05/2018 - 08/2004
33	Bipolar Disorder (Manic Depressive Psychosis) 05/2018 - 02/2005
8	Treatment-Resistant Depressive Disorder 05/2018 - 06/2013
8	Mania (Manias) 01/2013 - 03/2005
6	Alcoholism (Alcohol Abuse) 01/2017 - 01/2009
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2013 - 02/2005
4	Mood Disorders (Mood Disorder) 01/2017 - 02/2002
3	Syndrome (Syndromes) 05/2018 - 03/2002
3	Depressive Disorder (Melancholia) 06/2013 - 07/2004
2	Anhedonia 01/2017 - 05/2015
2	Panic Disorder (Panic Attack) 05/2013 - 01/2004
2	Substance-Related Disorders (Drug Abuse) 01/2013 - 08/2011
1	Amnesia (Dissociative Amnesia) 05/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Symptom Flare Up 05/2016
1	Fatigue 04/2016
1	Anxiety Disorders (Anxiety Disorder) 03/2016
1	Pancreatitis 05/2014
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 05/2014
1	Autism Spectrum Disorder 05/2014
1	Hypokinesia (Bradykinesia) 11/2012
1	Parkinson Disease (Parkinson's Disease) 11/2012
1	IgA Deficiency 06/2012
1	Sleepiness 10/2011
1	Tremor (Tremors) 09/2011
1	Essential Tremor (Essential Tremors) 09/2011
1	Movement Disorders (Movement Disorder) 09/2011
1	Sleep Deprivation 08/2011
1	Task-Specific Focal Dystonia 08/2011
1	Wounds and Injuries (Trauma) 08/2011
1	Dystonic Disorders (Writer's Cramp) 08/2011
1	Disease Progression 02/2011

Drug/Important Bio-Agent (IBA)

33	Antidepressive Agents (Antidepressants)IBA 05/2018 - 02/2005
30	Ketamine FDA LinkGeneric 05/2018 - 01/2009
12	N-Methylaspartate (NMDA)IBA 02/2015 - 01/2006
11	LithiumIBA 01/2017 - 07/2004
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2016 - 12/2006
7	Valproic Acid (Depakote)FDA LinkGeneric 01/2017 - 07/2004
5	Serotonin (5 Hydroxytryptamine)IBA 05/2013 - 01/2004
4	Riluzole FDA LinkGeneric 05/2015 - 02/2005
4	Glucose (Dextrose)FDA LinkGeneric 05/2015 - 03/2002
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2015
3	CatecholaminesIBA 10/2011 - 05/2008
3	salicylhydroxamic acid (SHAM)IBA 08/2011 - 04/2005
3	Tryptophan (L-Tryptophan)FDA Link 09/2006 - 08/2004
2	Pharmaceutical PreparationsIBA 05/2016 - 08/2010
2	Glutamic Acid (Glutamate)FDA Link 04/2016 - 02/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 08/2011
2	Pramipexole (Mirapex)FDA LinkGeneric 07/2013 - 07/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 09/2012 - 08/2011
2	Dopamine (Intropin)FDA LinkGeneric 10/2011 - 05/2008
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2011 - 04/2005
2	Antipsychotic Agents (Antipsychotics)IBA 08/2008 - 11/2007
1	N 30IBA 01/2017
1	Anesthetics (Anesthetic Agents)IBA 01/2017
1	CytokinesIBA 01/2017
1	Glutamate Receptors (Glutamate Receptor)IBA 04/2016
1	Dihydrotachysterol (AT 10)IBA 04/2016
1	Proteins (Proteins, Gene)FDA Link 02/2015
1	EsketamineIBA 01/2015
1	Serine (L-Serine)FDA Link 01/2015
1	Transaminases (Aminotransferases)IBA 05/2014
1	AZD6765IBA 08/2013
1	Dopamine Agonists (Dopamine Agonist)IBA 07/2013
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 05/2013
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2012
1	CannabinoidsIBA 12/2012
1	Amino Acids FDA Link 09/2012
1	4-methylbenzyl 3- fluoro- 4- ((pyrimidin- 2- ylamino)methyl)piperidine- 1- carboxylateIBA 08/2012
1	Immunoglobulins (Immunoglobulin)IBA 06/2012
1	Scopolamine (Hyoscine)FDA Link 03/2012
1	alpha-Methyltyrosine (Metirosine)FDA Link 10/2011
1	ProlactinIBA 10/2011
1	TabletsIBA 09/2011
1	Therapeutic UsesIBA 09/2011
1	Ethanol (Ethyl Alcohol)IBA 09/2011
1	Substance PIBA 08/2011
1	Corticotropin-Releasing HormoneIBA 08/2011
1	Insulin (Novolin)FDA Link 08/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2011
1	Nerve Growth Factors (Neurotrophins)IBA 08/2011
1	NeuropeptidesIBA 08/2011
1	Interleukin-6 (Interleukin 6)IBA 08/2011
1	Paroxetine (Paxil)FDA LinkGeneric 08/2011
1	Neurokinin-1 Receptor AntagonistsIBA 03/2011
1	vofopitantIBA 03/2011
1	Biological ProductsIBA 02/2011
1	Uric Acid (Urate)IBA 08/2010
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2009
1	Verapamil (Calan)FDA LinkGeneric 12/2008
1	Purinergic AgentsIBA 08/2008
1	Dipyridamole (Persantine)FDA LinkGeneric 08/2008
1	Allopurinol (Remid)FDA LinkGeneric 08/2008

Therapy/Procedure

7	Therapeutics 05/2014 - 11/2007
2	Transcranial Magnetic Stimulation 11/2012 - 01/2009
2	Activities of Daily Living (ADL) 11/2012 - 09/2011
1	Intravenous Administration 06/2012
1	Aftercare (After-Treatment) 08/2011
1	Transcranial Direct Current Stimulation 08/2011
1	Treatment Delay 07/2010